drugset
drugset / Trial / NCT06744868

A Single- and Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of THDBH120 Injection in Healthy Subjects

NCT06744868 ↗

Phase 1 Completed 72 enrolled Tonghua Dongbao Pharmaceutical Co.,Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

This study includes single-ascending dose cohorts (SAD cohorts) and multiple-ascending dose cohorts (MAD cohorts). The aim of this trial is to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of THDBH120 injection in healthy patients.

Timeline

Start
2023-12-19
Primary completion
2024-09-22
Completion
2024-09-22

Drugs

EvaluationDrugModalityDoseRoute
Subject THDBH120 Unknown — Subcutaneous

Indications

No indication recorded.